PANCREAS CANCER

This study tested whether remote monitoring could help patients with advanced pancreatic cancer better tolerate their chemotherapy. Patients used a chest sensor, smart scale, and tablet to track symptoms, weight, and activity from home. The goal was to spot early warning signs an…

This was a first-in-human study to find a safe dose of a new experimental cancer drug called SNB-101. The drug, a nanoparticle form of an existing chemotherapy, was given by IV to 21 patients with advanced solid tumors that had stopped responding to standard treatments. The main …

This small, early-stage study aimed to see if it was safe to add a drug called anakinra (used for rheumatoid arthritis) to standard chemotherapy for people with advanced pancreatic cancer that had spread. The main goal was to check for side effects and safety issues in this new c…

This early-stage trial tested a personalized vaccine designed to teach the immune system to attack a patient's specific pancreatic cancer. It involved 33 patients who had already received chemotherapy. The main goal was to check if the vaccine was safe. Researchers also measured …

This study tested a two-step treatment for advanced pancreatic cancer. First, patients received standard chemotherapy plus experimental drugs designed to make cancer cells more vulnerable. If their disease was controlled after three cycles, they moved to a second phase receiving …

This study tested whether combining two drugs, pembrolizumab (an immunotherapy) and azacitidine, could help control advanced pancreatic cancer that had worsened after initial chemotherapy. All 36 participants received the combination to see if it could slow cancer growth and was …

This large, completed study aimed to find out which of two commonly used antibiotics works better at preventing surgical site infections after a major pancreatic surgery called pancreatoduodenectomy. Nearly 1,000 adult patients scheduled for this surgery were randomly assigned to…

This study tested whether doctors could safely take small samples of a patient's pancreatic cancer tumor and grow miniature 3D versions (organoids) in the lab. Researchers then used these mini-tumors to test which chemotherapy drugs worked best against that specific patient's can…

This study tested a digital tool designed to help cancer survivors learn about and decide whether to get genetic testing for hereditary cancer risk. Researchers wanted to see if this smart technology was easy to use and if it encouraged more people to get tested. They compared th…